Outside Review of Clinical Data Finds a Spinal Treatment’s Benefit Overstated

http://www.nytimes.com/2013/06/18/business/infuse-a-spinal-treatment-found-no-better-than-older-remedy.html?partner=rss&emc=rss

Independent reviews of clinical trial data concluded that Infuse, a bioengineered bone product, was not significantly better than a traditional bone graft, and that it might pose risks.

Sent by gReader Pro

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s